Quinapril to lisinopril
Searched over 200M research papers
Summary
10 papers analyzed
Some studies suggest lisinopril is more effective in reducing blood pressure, while other studies indicate quinapril may be more effective or equally effective, with both drugs showing similar tolerance and adverse effects.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Comparative Efficacy and Safety of Quinapril and Lisinopril in Hypertension Treatment
Introduction to ACE Inhibitors in Hypertension
Angiotensin-converting enzyme (ACE) inhibitors, such as quinapril and lisinopril, are commonly prescribed for managing hypertension. These medications help relax blood vessels, making it easier for the heart to pump blood. This article synthesizes research comparing the efficacy and safety of quinapril and lisinopril in treating mild to moderate hypertension.
Efficacy in Blood Pressure Reduction
Lisinopril vs. Quinapril: Blood Pressure Control
Several studies have demonstrated that both lisinopril and quinapril effectively reduce blood pressure in patients with mild to moderate hypertension. However, lisinopril appears to have a more pronounced effect. In one study, lisinopril normalized blood pressure in 83% of patients compared to 45% for quinapril after 4 and 8 weeks of treatment. Another study using ambulatory blood pressure monitoring (ABPM) found that lisinopril significantly reduced systolic and diastolic blood pressure more than quinapril .
Long-term Efficacy
Over a 12-week period, both drugs showed significant reductions in systolic and diastolic blood pressure. However, quinapril demonstrated a greater reduction in systolic blood pressure at week 4 and diastolic blood pressure at week 8 compared to lisinopril. This suggests that while lisinopril may offer more immediate control, quinapril could provide sustained benefits over a longer period.
Safety and Tolerability
Adverse Effects
Both medications are generally well-tolerated, but there are some differences in their safety profiles. Lisinopril has been associated with rare cases of hepatotoxicity, as evidenced by a case where a patient developed liver issues that resolved after discontinuing lisinopril. On the other hand, quinapril has shown a more consistent control of hypertension in elderly patients with low blood renin levels, indicating its safety and efficacy in this subgroup.
Biochemical and Hematological Changes
Both drugs have been shown to cause changes in biochemical parameters. For instance, decreases in basal glycemia and cholesterol levels were observed in patients treated with quinapril . Additionally, both drugs led to an increase in serum potassium levels, which is a common side effect of ACE inhibitors.
Mechanisms of Action and Additional Benefits
Impact on Left Ventricular Hypertrophy
ACE inhibitors like lisinopril and quinapril also affect cardiac structure. Studies have shown that these drugs can reduce left ventricular hypertrophy, a common complication of hypertension, by lowering insulin-like growth factor-1 (IGF-1) levels. This reduction in IGF-1 is associated with a decrease in left ventricular mass, suggesting that both drugs can provide cardiac benefits beyond blood pressure reduction.
Matrix Metalloproteinase Activity
Research indicates that ACE inhibitors can inhibit matrix metalloproteinase (MMP) activity, which plays a role in preventing left ventricular remodeling in heart failure models. This effect was observed with both lisinopril and quinapril, highlighting their potential in managing heart failure.
Conclusion
Both lisinopril and quinapril are effective in managing mild to moderate hypertension, with lisinopril showing a more immediate impact on blood pressure reduction. Quinapril, however, may offer sustained benefits over a longer period. Both drugs are generally well-tolerated, though lisinopril has been associated with rare cases of hepatotoxicity. Additionally, both medications provide cardiac benefits by reducing left ventricular hypertrophy and inhibiting MMP activity. These findings suggest that the choice between lisinopril and quinapril should be tailored to the individual patient's needs and medical history.
Sources and full results
Most relevant research papers on this topic
